TGFB1 and cancer: A recent study reported that high levels of TGF-β1 were released from platelet α-granules, and that the TGF-β1 could induce an epithelial-mesenchymal cancer cell transition (EMT) [10,11], a transient and reversible process that promotes cancer cell motility, invasiveness, and metastasis [12-14].